Genprex , Inc., a pharmaceutical company based in Austin, Texas, has received notifications from The Nasdaq Stock Market indicating non-compliance with certain listing requirements. Currently trading ...
The transfer of LeddarTech’s listing to the Nasdaq Capital Market indicates the company has addressed previous compliance issues and met the applicable standards, which could instill confidence ...
It witnessed improved results from both the Banking Solutions and Capital Market Solutions units. Improved higher-margin license revenues benefited the Capital Market Solutions segment.
Emeth Value Capital, an investment management firm, released its fourth quarter 2024 investor letter. A copy of the letter ...
Barchart on MSN7d
Nasdaq Stock: Is Wall Street Bullish or Bearish?Valued at a market cap of $47.6 billion, Nasdaq, Inc. (NDAQ) is a global financial technology, trading, and market ...
SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...
SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...
We recently published an article titled Why These Dividend Stocks are Gaining in 2025? In this article, we are going to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback